J Lipid Atheroscler.
2024 Sep;13(3):306-327. 10.12997/jla.2024.13.3.306.
Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components
- Affiliations
-
- 1Department of Nutritional Sciences, University of Connecticut, Storrs, CT, USA
- KMID: 2559855
- DOI: http://doi.org/10.12997/jla.2024.13.3.306
Abstract
- Dysfunctional mitochondria have been linked to the pathogenesis of obesity-associated metabolic diseases. Excessive energy intake impairs mitochondrial biogenesis and function, decreasing adenosine-5’-triphosphate production and negatively impacting metabolically active tissues such as adipose tissue, skeletal muscle, and the liver. Compromised mitochondrial function disturbs lipid metabolism and increases reactive oxygen species production in these tissues, contributing to the development of insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease. Recent studies have demonstrated the therapeutic potential of bioactive food components, such as resveratrol, quercetin, coenzyme Q10, curcumin, and astaxanthin, by enhancing mitochondrial function. This review provides an overview of the current understanding of how these bioactive compounds ameliorate mitochondrial dysfunction to mitigate obesity-associated metabolic diseases.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Macrophage and Adipocyte Mitochondrial Dysfunction in Obesity-Induced Metabolic Diseases
- Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- The Link between Mitochondrial Dysfunction and Sarcopenia: An Update Focusing on the Role of Pyruvate Dehydrogenase Kinase 4
- Strategies for Prevention of Food Poisoning
- Effects of Functional Food Components in Reducing Obesity-induced Inflammation and Metabolic Diseases
